|  | Numbers (n) | Percent (%) |
---|---|---|---|
Age (years) | Â | Â | |
 | Mean ± SD (range) | 64.8 | ±9.8 (31-81) |
Gender | Â | Â | Â |
 | Male | 68 | 66.7 |
 | Female | 34 | 33.3 |
Cigarette smoking | Â | Â | |
 | Never smoked | 34 | 33.3 |
 | Ex-smoker | 20 | 19.6 |
 | Current smoker | 48 | 47.1 |
 | Pack-year/Mean ± SD (range) | 36.6 | ±36.8 (0-180) |
Tumor differentiation | Â | Â | |
 | Well | 16 | 15.7 |
 | Moderate | 53 | 52.0 |
 | Poor | 32 | 31.4 |
 | Unknown | 1 |  |
Tumor stage | Â | Â | |
 | II | 31 | 30.4 |
 | III | 60 | 58.8 |
 | IV | 11 | 10.8 |
Operation method | Â | Â | |
 | Pneumonectomy | 1 | 1.0 |
 | Bilobectomy | 1 | 1.0 |
 | Lobectomy | 83 | 81.4 |
 | Segmentectomy | 9 | 8.8 |
 | Partial resection | 8 | 7.8 |
Complete resection | Â | Â | |
 | Yes | 77 | 75.5 |
 | No | 25 | 24.5 |
Preoperative chemotherapy | Â | Â | |
 | Yes | 9 | 8.8 |
 | No | 93 | 91.2 |
Postoperative chemotherapy | Â | Â | |
 | Yes | 74 | 72.5 |
 | No | 28 | 27.5 |
Radiotherapy to thorax (chest wall or mediastinum)a | Â | Â | |
 | Yes (Pre/Post) | 5 (1/4) | 4.9 |
 | No | 97 | 95.1 |
EGFR gene mutation status | Â | Â | |
 | Wild-type | 46 | 45.1 |
 | Mutation (+) | 33 | 32.4 |
 | Unknown | 23 | 22.5 |
Recurrenceb | Â | Â | Â |
 | Yes | 82 | 80.4 |
 | No | 20 | 19.6 |
Prognosis | Â | Â | Â |
 | Alive | 33 | 34.4 |
 | Dead | 63 | 65.6 |